Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

Core Viewpoint - Kiniksa Pharmaceuticals International, plc will host a conference call on February 25, 2025, to discuss its fourth quarter and full year 2024 financial results and recent portfolio execution [1]. Group 1: Conference Call Details - The conference call is scheduled for 8:30 a.m. Eastern Time on February 25, 2025 [1]. - A live webcast will be available on the company's website, and participants can register for telephone access [2]. - A replay of the event will be accessible on Kiniksa's website within approximately 48 hours after the event [2]. Group 2: Company Overview - Kiniksa is a biopharmaceutical company focused on developing novel therapies for debilitating diseases, particularly in cardiovascular indications [3]. - The company's portfolio is based on strong biologic rationale or validated mechanisms, offering potential for differentiation in the market [3].